Paul Tudor Jones’s Medifast MED Stock Holding History

Paul Tudor Jones’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$807K	Buy	+76,031	New	+$877K	﹤0.01%	2563
2024 Q3	–	Sell	-47,954	Closed	-$924K	–	2956
2024 Q2	$1.05M	Buy	+47,954	New	+$1.28M	0.01%	1436
2023 Q2	–	Sell	-2,789	Closed	-$248K	–	2742
2023 Q1	$289K	Buy	+2,789	New	+$309K	﹤0.01%	1955
2021 Q3	–	Sell	-4,868	Closed	-$1.38M	–	2662
2021 Q2	$1.38M	Buy	+4,868	New	+$1.32M	0.03%	722
2020 Q1	–	Sell	-16,627	Closed	-$1.82M	–	1211
2019 Q4	$1.82M	Sell	16,627 -12,873	-44%	-$1.25M	0.08%	318
2019 Q3	$3.06M	Sell	29,500 -194	-0.7%	-$20.9K	0.1%	214
2019 Q2	$3.81M	Buy	29,694 +23,564	+384%	+$3.27M	0.11%	145
2019 Q1	$782K	Buy	+6,130	New	+$778K	0.03%	548
2018 Q3	–	Sell	-4,355	Closed	-$697K	–	1181
2018 Q2	$697K	Buy	4,355 +1,806	+71%	+$231K	0.02%	563
2018 Q1	$238K	Buy	+2,549	New	+$190K	0.01%	811
2017 Q2	–	Sell	-5,667	Closed	-$251K	–	1233
2017 Q1	$251K	Sell	5,667 -3,633	-39%	-$156K	0.01%	1104
2016 Q4	$387K	Buy	9,300 +3,578	+63%	+$144K	0.01%	868
2016 Q3	$216K	Sell	5,722 -19,378	-77%	-$695K	0.01%	1216
2016 Q2	$835K	Buy	25,100 +8,200	+49%	+$265K	0.02%	537
2016 Q1	$510K	Buy	+16,900	New	+$494K	0.01%	934
2014 Q1	–	Sell	-9,600	Closed	-$251K	–	1332
2013 Q4	$251K	Buy	+9,600	New	+$246K	0.01%	984
2013 Q3	–	Sell	-11,300	Closed	-$291K	–	905
2013 Q2	$291K	Buy	+11,300	New	+$297K	0.02%	568

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Paul Tudor Jones's MED Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Medifast (MED) in Q2 2026: 76,031 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #2563 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in MED as recently as Q2 2024.

Paul Tudor Jones first reported a position in MED in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.81M in Q2 2019. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Paul Tudor Jones held 76,031 shares of Medifast worth $807K as of Q2 2026.
Medifast was a new Paul Tudor Jones position in Q2 2026.
Medifast made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2563 holding.
Paul Tudor Jones first reported a position in Medifast in Q2 2013 and has held it in 17 quarters since.
Paul Tudor Jones's Medifast position peaked at $3.81M in Q2 2019.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.